Cardiac Arrest Treatment Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM Intelligence
Market Overview:
Cardiac Arrest Treatment Market size was valued at US$ 16,230 million in 2021 and is estimated to reach US$ 24,690 million by 2029, growing at a CAGR of 9.21% during the forecast period (2022-2029).
Cardiac arrest is a sudden and abrupt lack of coronary heart function, cognizance, and apnea. It originates from an electrical disturbance prompted in the coronary heart because of a lag in electric signal impulses. The primary motive of cardiac arrest is extraordinary coronary heart rhythm like ventricular tachycardia.
To Download free sample @ Click Here
Market Dynamics
The growing sedentary way of life is predicted to pressure the market growth
The rising sedentary life-style is anticipated to reinforce the marketplace over the forecast length. As in keeping with World Health Organization, sedentary lifestyles kill many people around the world. Insufficient bodily activity is the 4th leading risk issue for mortality.
Approximately 3.1 million deaths and 32.1 million DALYs (representing about 2.1% of world DALYs) every 12 months are a consequence of inadequate bodily pastime. People who’re insufficiently physically active have a 20% to 30% elevated chance of all-cause mortality as compared to individuals who engage in at least 30 minutes of mode bodily pastime maximum days of the week. Prevalence of insufficiently bodily active folks elderly 18+ years.
The presence of research and development sports for the treatment of cardiac arrest is expected to boost the marketplace. For example, on Aug 29, 2022, Bayer confirmed that Kerendia cut the incidence of unexpected cardiac demise throughout a huge variety of sufferers with early- to late-degree CKD and diabetes.
The result got here from a prespecified, pooled evaluation of certain sufferers in the Fidelio-DKD and Figaro-DKD studies. While Kerendia narrowly neglected the statistical significance bar for cutting all-reason and cardiovascular mortality inside the ordinary take a look at populations, a prespecified analysis of sufferers with CKD and kind 2 diabetes changed into more favorable for the drug.
Market Segmentation:
By Treatment type
- Beta-blockers
- Vasopressors
- Anti-arrhythmic drugs
- Anticholinergic drugs
By Distribution channel
- Hospitals*
- Independent pharmacies
Competitive Landscape
The cardiac arrest treatment market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Koninklijke Philips N.V., ZOLL Medical Corporation, GE Healthcare, Stryker, Boston Scientific Corporation, Cardiac Science Corporation (Aurora Capital Group), Bristol-Myers Squibb Company, and Abbott. among others.
The major players are adopting several growth strategies such as Treatment type launches, acquisitions, and collaborations, which are contributing to the growth of the cardiac arrest treatment market globally.
Trending Topics:
Acute Coronary Syndrome Market
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/cardiac-arrest-treatment-market
